Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?

J Infect Dis. 2016 Apr 15;213(8):1211-3. doi: 10.1093/infdis/jiv459. Epub 2015 Oct 28.

Authors

Robert L Atmar¹, Wendy A Keitel¹

Affiliation

¹ Department of Medicine Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.

PMID: 26516140
DOI: 10.1093/infdis/jiv459

No abstract available

Keywords: immunogenicity; influenza; influenza vaccines; statins; vaccine effectiveness.

Publication types

Editorial
Comment

MeSH terms

Anti-Inflammatory Agents / adverse effects*
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Influenza Vaccines / immunology*
Influenza, Human / prevention & control*
Male
Respiratory Tract Infections / immunology*

Substances

Anti-Inflammatory Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Influenza Vaccines